Agilent Technologies (NYSE:A) will post its quarterly earnings results after the market closes on Tuesday, August 14th. Analysts expect Agilent Technologies to post earnings of $0.63 per share for the quarter. Agilent Technologies has set its Q3 guidance at $0.61-0.63 EPS and its FY18 guidance at $2.63-2.67 EPS.
Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Monday, May 14th. The medical research company reported $0.65 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.64 by $0.01. The firm had revenue of $1.21 billion during the quarter, compared to analyst estimates of $1.21 billion. Agilent Technologies had a return on equity of 18.01% and a net margin of 5.02%. Agilent Technologies’s quarterly revenue was up 9.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.58 EPS. On average, analysts expect Agilent Technologies to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.
Agilent Technologies opened at $66.26 on Monday, according to MarketBeat. The company has a quick ratio of 2.88, a current ratio of 3.32 and a debt-to-equity ratio of 0.39. The stock has a market capitalization of $21.34 billion, a PE ratio of 28.08, a P/E/G ratio of 2.33 and a beta of 1.29. Agilent Technologies has a 1 year low of $58.69 and a 1 year high of $75.00.
Several equities research analysts recently commented on the company. Zacks Investment Research upgraded Agilent Technologies from a “hold” rating to a “buy” rating and set a $74.00 price objective for the company in a report on Tuesday, August 7th. ValuEngine upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a report on Wednesday, July 25th. Finally, Cowen upgraded Agilent Technologies from a “market perform” rating to an “outperform” rating in a report on Tuesday, May 15th. One research analyst has rated the stock with a hold rating and eleven have given a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $74.64.
In related news, Director Boon Hwee Koh sold 6,931 shares of Agilent Technologies stock in a transaction dated Tuesday, June 12th. The stock was sold at an average price of $66.38, for a total value of $460,079.78. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; microfluidics based automated electrophoresis products; cell analysis plate based assays; laboratory software and informatics systems; laboratory automation; dissolution testing; vacuum pumps; and measurement technologies.
Further Reading: How to Invest in Growth Stocks
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.